Trial intelligence / Profile preview

STEP-Mag Trial

PACTR202112816270738Phase 3Not yet recruiting

Sponsor
World Health Organization
Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of magnesium sulfate in preeclampsia, sponsored by World Health Organization. Planned start Mar 2022; status: not yet recruiting.

02

Drugs

magnesium sulfate
03

Conditions

preeclampsia

Beyond the preview

Go deeper on PACTR202112816270738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202112816270738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call